Abstract
Sera from SIV-infected macaques were found to contain antibodies that reacted with conformation-dependent, group-specific determinants on the SIV envelope protein gp130. These conformation-dependent antibodies exhibited virus neutralizing activity; their presence was associated with protection in vaccine studies. The properties of these antibodies are quite similar to those that have been identified in sera from HIV-infected human subjects. These data suggest that the SIV envelope gp130 remains a candidate for subunit vaccine studies.
Original language | English (US) |
---|---|
Pages (from-to) | 82-90 |
Number of pages | 9 |
Journal | Journal of medical primatology |
Volume | 21 |
Issue number | 2-3 |
State | Published - 1992 |
Externally published | Yes |
ASJC Scopus subject areas
- Animal Science and Zoology
- veterinary(all)